Paul Tudor Jones’s Medtronic MDT Stock Holding History

Paul Tudor Jones’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.34M	Sell	42,700 -43,600	-51%	-$3.52M	﹤0.01%	1568
2026 Q1	$7.48M	Buy	86,300 +54,300	+170%	+$5.2M	0.01%	920
2025 Q4	$3.07M	Buy	32,000 +24,600	+332%	+$2.39M	0.01%	1489
2025 Q3	$705K	Sell	7,400 -51,700	-87%	-$4.75M	﹤0.01%	2496
2025 Q2	$5.15M	Buy	59,100 +40,000	+209%	+$3.39M	0.01%	1071
2025 Q1	$1.72M	Sell	19,100 -35,900	-65%	-$3.21M	0.01%	1454
2024 Q4	$4.39M	Buy	55,000 +34,500	+168%	+$2.99M	0.02%	768
2024 Q3	$1.85M	Sell	20,500 -19,600	-49%	-$1.65M	0.01%	1243
2024 Q2	$3.16M	Buy	40,100 +13,800	+52%	+$1.13M	0.02%	841
2024 Q1	$2.29M	Sell	26,300 -10,800	-29%	-$922K	0.01%	958
2023 Q4	$3.06M	Sell	37,100 -3,000	-7%	-$229K	0.02%	888
2023 Q3	$3.14M	Buy	+40,100	New	+$3.36M	0.03%	712
2023 Q2	–	Sell	-3,200	Closed	-$257K	–	2741
2023 Q1	$257K	Sell	3,200 -34,200	-91%	-$2.79M	﹤0.01%	2033
2022 Q4	$2.91M	Buy	+37,400	New	+$3.03M	0.06%	444

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Paul Tudor Jones's MDT Position: Q2 2026 in Review

Paul Tudor Jones increased its Medtronic (MDT) stake by 1,330% in Q2 2026, buying an estimated $4.93M and bringing the position to 65,665 shares worth $5.14M. The position accounts for 0.01% of the portfolio, ranked #1260.

Paul Tudor Jones first reported a position in MDT in Q2 2013 and has held it in 42 quarters since. The position peaked at $29M in Q1 2023. 2,126 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Paul Tudor Jones held 65,665 shares of Medtronic worth $5.14M as of Q2 2026.
Paul Tudor Jones bought 61,074 Medtronic shares in Q2 2026, an estimated $4.93M.
Medtronic made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1260 holding.
Paul Tudor Jones first reported a position in Medtronic in Q2 2013 and has held it in 42 quarters since.
Paul Tudor Jones's Medtronic position peaked at $29M in Q1 2023.
2,126 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.